Research graph
References from Baseline CSF tau and short‐term clinical change during lecanemab therapy: A prospective real‐world cohort study in Japan. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1056/nejmoa2212948
10.1056/nejmoa2212948 · External reference
10.1001/jama.2023.13239
10.1001/jama.2023.13239 · External reference
10.1002/dad2.12131
10.1002/dad2.12131 · External reference
10.3233/jad‐160722
10.3233/jad‐160722 · External reference
10.1002/acn3.51681
10.1002/acn3.51681 · External reference
10.1002/alz.12316
10.1002/alz.12316 · External reference
10.1016/j.jalz.2018.02.018
10.1016/j.jalz.2018.02.018 · External reference
10.1016/j.jalz.2011.03.005
10.1016/j.jalz.2011.03.005 · External reference
10.1016/s1474‐4422(20)30071‐5
10.1016/s1474‐4422(20)30071‐5 · External reference
10.1016/s1474‐4422(21)00214‐3
10.1016/s1474‐4422(21)00214‐3 · External reference
10.1001/jamaneurol.2020.4986
10.1001/jamaneurol.2020.4986 · External reference
10.1093/brain/awaa286
10.1093/brain/awaa286 · External reference
10.1002/1097‐0142(1950)3:1%3c32::aid‐cncr2820030106%3e3.0.co;2‐3
10.1002/1097‐0142(1950)3:1%3c32::aid‐cncr2820030106%3e3.0.co;2‐3 · External reference
10.2307/2531595
10.2307/2531595 · External reference
Selecting optimal cut‐off values in receiver operating characteristic curve analysis: a review
2022 · External reference
10.1186/s13195‐025‐01912‐6
10.1186/s13195‐025‐01912‐6 · External reference
